High Street Partners, an Annapolis, Md.-based provider of international business services, has raised $6 million in Series B funding. Sigma Partners led the round, and was joined by Baird Venture Partners and return backer SVB Financial Group.
4 min read · 03 May 2010
1 min read · 03 May 2010
Nualight Ltd., a Cork, Ireland-based maker of LED lighting solutions for retailers, has raised €9.1 million in VC funding. Climate Change Capital Private Equity led the round, and was joined by 4th Level Ventures and return backer ESB novusmodus (affiliate of the Irish State electricity company).
4 min read · 03 May 2010
Cloud Sherpas, an Atlanta-based provider of Google Apps solutions, has raised $1 million in VC funding led by new CEO Jon Hallett, former executive chairman at Northridge Systems.
3 min read · 03 May 2010
Alphabet Energy Inc., a Berkeley, Calif.-based developer of inexpensive waste heat recovery technology, has raised $1 million in seed funding from Claremont Creek Ventures and the CalCEF Clean Energy Angel Fund.
4 min read · 03 May 2010
Sigma Offshore, a UK-based developer of a mooring and fluid transfer system for oil and gas production vessels, has raised £4 million in VC funding. Backers include National Oilwell Varco, Scottish Enterpprise and Energy Ventures.
3 min read · 03 May 2010
Robert Chiste has joined El Dorado Ventures as an executive-in-residence, with a focus on the cleantech space. He is the former chairman, president and CEO of Comverge (Nasdaq: COMV), a provider of energy efficiency and demand management solutions for the utility, commercial and industrial markets.
2 min read · 03 May 2010
Montagu Newhall Associates has changed its name to Greenspring Associates. The Owings Mills, Md.-based firm manages venture capital funds-of-funds and makes direct co-investments.
2 min read · 03 May 2010
XOS Digital Inc., a provider of digital technology and media management solutions to collegiate and professional sports organizations, has raised an undisclosed amount of Series B funding. NewSpring Capital and Dublin Capital were joined on the round by return backers Blue Chip Venture Co. and Beechtree Capital.
2 min read · 30 April 2010
Affimed Therapeutics AG, a German antibody developer, has raised €20 million in Series C funding. Return backers included Aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk and Orbimed Advisors. The company said that future Series C commitments "at a later date."
2 min read · 30 April 2010
